The old way of estimating heart attack and stroke risk is being retired. If you haven’t heard yet, new cholesterol guidelines are coming into play. They replace the calculator doctors have relied on for over a decade. The result? About 20 percent of adults will land in a completely different risk category.
This isn’t just administrative shuffling. It changes who gets prescribed medication. It changes what your LDL cholesterol goal should be. And for some groups, it means a surprise uptick in risk that wasn’t there before.
Why the PREVENT Tool Replaced the Old Calculator
For years, doctors used a calculator based on data from the 1940s to the 1980s. It was five small groups. Decades old. Not representative of who we are today. Later studies showed it overestimated risk for men and Black adults. It underestimated it for others.
The replacement is called PREVENT.
Developed using data from 46 modern, diverse, and larger studies, this tool aims to be more accurate. It’s race-agnostic. That means you don’t enter race into the equation. Instead, it pulls in newer health metrics like kidney function and body mass index (BMI).
It also estimates both 10-year and 30-year risk for adults aged 30 to 79.
“The advantage of the new tool is that the lead data represent a more modern population,” says Eric J. Brandt, a preventive cardiologist at the University of Michigan.
Who Moved Up and Who Moved Down?
Researchers analyzed health data from nearly 25,00U.S. adults aged 40–79 with no known heart disease. They ran the numbers through both the old calculator and PREVENT.
Here’s the breakdown:
- 79 percent stayed in the same risk bucket.
- 14 percent dropped to a lower risk category.
- 7 percent climbed to a higher risk category.
The shift wasn’t random.
Women and people with diabetes were most likely to move up into higher risk. About 20 percent of adults with diabetes saw their risk rise. For women, that figure was around 11 percent.
Conversely, men, Black adults, and current smokers often moved down. This makes sense if you recall the old tool overestimating risk in these groups. The downward shift isn’t because smoking or high blood pressure became safer. It’s because the new tool is calibrated better.
“[The downward shifts] likely reflect better calibration, rather than a change in danger,” explains lead author Allison Peng, MD.
Why the Risk Shifted for Diabetes and Women
The reasons behind the moves aren’t fully settled.
For diabetics, it might just be the state of American health today. More people carry multiple health conditions. More people have risk factors than when the old data was collected. The new tool captures that reality.
Women are trickier. The study authors admit they aren’t sure why the upward shift happened for women specifically. The new 2026 guidelines do recommend considering “risk enhancers” for women—things like pregnancy complications or early menopause. But interestingly, the PREVENT tool itself doesn’t include those factors. So if a woman’s score jumps up, it’s not because PREVENT penalizes her for those events. It’s something else.
How This Changes Your LDL Cholesterol Goal
Risk score changes drive treatment decisions.
Under the new guidelines, cholesterol-lowering statins are generally recommended when your 10-year risk hits 5 percent. Between 3 and 5 percent? That’s the gray zone. Your doctor will look at other factors. Family history. Other medical conditions. Your personal preferences.
If you’re prescribed medication, your target LDL changes based on that risk level:
- Low Risk: LDL below 100 mg/dL.
- High Risk: LDL below 70 mg/dL.
- Very High Risk: LDL below 55 mg/dL. (Applies to those with existing heart disease).
For those in the borderline or intermediate zones, it gets fuzzy. You might need more testing to pin down the right number.
The LDL Gap Is Still Huge
Here’s the hard truth: many of you are currently failing the new goals.
An editorial accompanying the study notes that 32 percent of adults trying not to have a first heart attack already have high LDL. That number skyrockets to nearly 83 percent for those at highest risk. For adults who already have heart disease, almost 80 percent have inadequately controlled cholesterol.
The bar has been raised. And many are falling short.
Beyond the Score: Additional Tests
Your doctor might order more than just a standard lipid panel now.
A coronary artery calcium (CAC) scan looks directly for plaque in the arteries. A lipoprotein(a) test checks for inherited cardiovascular risk.
Nishant Shah, a researcher at Duke University School of Medicine, recommends everyone check their lipoprotein(a) at least once in their life. It’s one data point that standard tests miss.
Strengths and Gaps in the Data
The study is large. Nationally representative. That gives it weight. It allows experts to project how these changes will affect different demographics.
But it’s not a perfect crystal ball.
The research looked at how people moved between categories. It didn’t follow patients for years to see who actually had heart attacks. We don’t yet know if PREVENT predicts real-world outcomes better than the old calculator. That requires longitudinal data we don’t have yet.
Also, the analysis only covered adults 40 to 79. PREVENT can technically be used for people starting at age 30. But the data for that younger slice isn’t part of this specific report.
What to Ask Your Doctor
Proactive is better than reactive. When your next checkup comes up, don’t just accept the old numbers.
Ask:
- Is my cardiovascular risk being managed as well as possible?
- What is my specific LDL goal?
- Do I need additional testing—like a CAC scan or lipoprotein(a) test—to define my risk more accurately?
- Does the new PREVENT tool change my treatment plan?
The guidelines are shifting. The tools are getting smarter. But the conversation between you and your doctor needs to keep pace.
The science is evolving. You should too.
